Medtronic
Stock Forecast, Prediction & Price Target
Medtronic (MDT) stock Price Target by analysts
Medtronic (MDT) stock Price Target by analysts
Average Price Target
$99.25
Potential upside: 10.31%
Medtronic price prediction
What is Medtronic stock analysts` prediction?
Medtronic stock forecast: Based on 4 Wall Street analysts` predicted price targets for Medtronic in the last 3 months, the avarage price target is $99.25, with a high forecast of $NaN. The average price target represents a 10.31% change from the last price of $89.97.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Medtronic stock Price Target by analysts
Full breakdown of analysts given Medtronic price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
David Rescott Robert W. Baird | 0% 0/3 | 11 months ago | $96 6.70% upside | $90.01 | StreetInsider | Previous targets (2) |
Shagun Singh RBC Capital | 0% 0/2 | 11 months ago | $105 16.70% upside | $88.35 | TheFly | Previous targets (1) |
Joanne Wuensch Citigroup | 0% 0/2 | 11 months ago | $92 2.25% upside | $90.03 | TheFly | Previous targets (1) |
Vijay Kumar Evercore ISI | 0% 0/1 | 11 months ago | $104 15.59% upside | $90.03 | TheFly | Previous targets (0) |
Matt O'Brien Piper Sandler | 50% 1/2 | about 1 year ago | $90 0.03% upside | $85.38 | TheFly | Previous targets (1) |
Larry Biegelsen Wells Fargo | 16.67% 1/6 | about 1 year ago | $106 17.81% upside | $85.38 | TheFly | Previous targets (5) |
Steven Lichtman Oppenheimer | 0% 0/1 | about 1 year ago | $94 4.47% upside | $86.46 | StreetInsider | Previous targets (0) |
David Roman Goldman Sachs | 0% 0/1 | about 1 year ago | $82 -8.85% downside | $86.4 | StreetInsider | Previous targets (0) |
Anthony Petrone Mizuho Securities | 0% 0/1 | about 1 year ago | $98 8.92% upside | $86.38 | StreetInsider | Previous targets (0) |
Rick Wise Stifel Nicolaus | 0% 0/2 | about 1 year ago | $87 -3.30% downside | $85.38 | TheFly | Previous targets (1) |
Larry Biegelsen Wells Fargo | 16.67% 1/6 | over 1 year ago | $105 16.70% upside | $81.38 | StreetInsider | Previous targets (5) |
Richard Newitter Truist Financial | 0% 0/1 | over 1 year ago | $88 -2.18% downside | $81.38 | StreetInsider | Previous targets (0) |
David Rescott Robert W. Baird | 0% 0/3 | over 1 year ago | $87 -3.30% downside | $81.91 | StreetInsider | Previous targets (2) |
Shagun Singh RBC Capital | 0% 0/2 | over 1 year ago | $92 2.25% upside | $81.38 | StreetInsider | Previous targets (1) |
Rick Wise Stifel Nicolaus | 0% 0/2 | over 1 year ago | $100 11.14% upside | $81.38 | StreetInsider | Previous targets (1) |
Larry Biegelsen Wells Fargo | 16.67% 1/6 | almost 2 years ago | $102 13.37% upside | $80.98 | Benzinga | Previous targets (5) |
David Rescott Robert W. Baird | 0% 0/3 | about 2 years ago | $90 0.03% upside | $82.94 | Benzinga | Previous targets (2) |
Larry Biegelsen Wells Fargo | 16.67% 1/6 | about 2 years ago | $100 11.14% upside | $87.29 | Benzinga | Previous targets (5) |
Unknown RBC Capital | N/A | over 2 years ago | $89 -1.07% downside | $80.86 | Benzinga | N/A |
Unknown Wells Fargo | N/A | almost 3 years ago | $77 -14.41% downside | $76.49 | Benzinga | N/A |
Unknown Barclays | N/A | almost 3 years ago | $85 -5.52% downside | $79.12 | Benzinga | N/A |
Unknown Citigroup | N/A | almost 3 years ago | $85 -5.52% downside | $77.93 | Benzinga | N/A |
Unknown Oppenheimer | N/A | almost 3 years ago | $85 -5.52% downside | $77.97 | Benzinga | N/A |
Pito Chickering Deutsche Bank | 50% 1/2 | almost 3 years ago | $80 -11.08% downside | $78.53 | TheFly | Previous targets (1) |
Cecilia Furlong Morgan Stanley | 50% 1/2 | almost 3 years ago | $88 -2.18% downside | $78.53 | TheFly | Previous targets (1) |
Unknown RBC Capital | N/A | almost 3 years ago | $102 13.37% upside | $78.85 | Benzinga | N/A |
Pito Chickering Deutsche Bank | 50% 1/2 | almost 3 years ago | $85 -5.52% downside | $83.4 | TheFly | Previous targets (1) |
Unknown RBC Capital | N/A | almost 3 years ago | $110 22.26% upside | $86.04 | Benzinga | N/A |
Larry Biegelsen Wells Fargo | 16.67% 1/6 | about 3 years ago | $96 6.70% upside | $90.22 | TheFly | Previous targets (5) |
Unknown Morgan Stanley | N/A | about 3 years ago | $101 12.25% upside | $89.32 | Benzinga | N/A |
Unknown Truist Financial | N/A | about 3 years ago | $97 7.81% upside | $88.9 | Benzinga | N/A |
Unknown Stifel Nicolaus | N/A | about 3 years ago | $105 16.70% upside | $88.94 | Benzinga | N/A |
Unknown Morgan Stanley | N/A | about 3 years ago | $103 14.48% upside | $89.04 | Benzinga | N/A |
Unknown Morgan Stanley | N/A | about 3 years ago | $114 26.70% upside | $95.85 | Benzinga | N/A |
Unknown Raymond James | N/A | over 3 years ago | $109 21.15% upside | $99.08 | Benzinga | N/A |
Unknown Truist Financial | N/A | over 3 years ago | $111 23.37% upside | $100.03 | Benzinga | N/A |
Unknown Citigroup | N/A | over 3 years ago | $117 30.04% upside | $98.6 | Benzinga | N/A |
Shagun Singh Chadha RBC Capital | 0% 0/1 | over 3 years ago | $122 35.60% upside | $99.08 | TheFly | Previous targets (0) |
Josh Jennings Cowen & Co. | 0% 0/2 | over 3 years ago | $117 30.04% upside | $99.08 | TheFly | Previous targets (1) |
Unknown Deutsche Bank | N/A | over 3 years ago | $121 34.48% upside | $98.25 | Benzinga | N/A |
Unknown Morgan Stanley | N/A | over 3 years ago | $115 27.82% upside | $98.25 | Benzinga | N/A |
Unknown Cowen & Co. | N/A | over 3 years ago | $117 30.04% upside | $97.37 | Benzinga | N/A |
Unknown RBC Capital | N/A | over 3 years ago | $122 35.60% upside | $98.27 | Benzinga | N/A |
Unknown Cowen & Co. | N/A | over 3 years ago | $125 38.93% upside | $104.12 | Benzinga | N/A |
Travis Steed Bank of America Securities | 0% 0/1 | over 3 years ago | $135 50.05% upside | $107.65 | Pulse 2.0 | Previous targets (0) |
Michael Matson Needham | 0% 0/1 | over 3 years ago | $124 37.82% upside | $105.84 | Pulse 2.0 | Previous targets (0) |
Jayson Bedford Raymond James | 0% 0/1 | over 3 years ago | $116 28.93% upside | $99.98 | TheFly | Previous targets (0) |
Matthew O'Brien Piper Sandler | 100% 1/1 | over 3 years ago | $105 16.70% upside | $102.54 | TheFly | Previous targets (0) |
Joanne Wuensch Citigroup | 0% 0/2 | over 3 years ago | $129 43.38% upside | $107.12 | StreetInsider | Previous targets (1) |
Matt O'Brien Piper Sandler | 50% 1/2 | over 3 years ago | $110 22.26% upside | $108.55 | Pulse 2.0 | Previous targets (1) |
Medtronic Financial Estimates
Medtronic Revenue Estimates
Medtronic EBITDA Estimates
Medtronic Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 4/29/2022 | 4/28/2023 | 4/26/2024 | 4/26/2026 | 4/28/2026 | 4/26/2027 | 4/28/2027 |
Revenue
% change YoY
| $31.68B N/A | $31.22B -1.44% | $32.36B 3.64% | Avg: $35.02B Low: $34.89B High: $35.23B avg. 8.22% | Avg: $35.24B Low: $34.73B High: $35.63B avg. 0.62% | Avg: $36.75B Low: $36.51B High: $37.00B avg. 4.28% | Avg: $37.18B Low: $36.65B High: $37.59B avg. 1.17% |
Net Income
% change YoY
| $5.03B N/A | $3.75B -25.42% | $3.67B -2.18% | Avg: $5.72B Low: $2.83B High: $6.47B avg. 55.75% | Avg: $5.68B Low: $5.06B High: $6.49B avg. -0.74% | Avg: $5.97B Low: $5.20B High: $6.94B avg. 5.17% | Avg: $8.50B Low: $8.34B High: $8.63B avg. 42.37% |
EBITDA
% change YoY
| $8.93B N/A | $8.47B -5.11% | $8.20B -3.20% | Avg: $9.65B Low: $9.62B High: $9.71B avg. 17.74% | Avg: $10.12B Low: $9.97B High: $10.23B avg. 4.81% | Avg: $10.13B Low: $10.06B High: $10.20B avg. 0.11% | Avg: $10.68B Low: $10.52B High: $10.79B avg. 5.38% |
EPS
% change YoY
| $3.75 N/A | $2.83 -24.53% | $2.77 -2.12% | Avg: $4.24 Low: $2.13 High: $4.87 avg. 52.93% | Avg: $4.39 Low: $3.8 High: $4.87 avg. 3.63% | Avg: $4.69 Low: $3.91 High: $5.22 avg. 6.71% | Avg: $6.38 Low: $6.26 High: $6.48 avg. 36.27% |
Operating Expenses
% change YoY
| $15.63B N/A | $14.67B -6.10% | $16.12B 9.88% | Avg: $11.72B Low: $11.67B High: $11.79B avg. -27.32% | Avg: $11.88B Low: $11.71B High: $12.01B avg. 1.39% | Avg: $12.29B Low: $12.21B High: $12.38B avg. 3.49% | Avg: $12.53B Low: $12.35B High: $12.67B avg. 1.94% |
FAQ
What is Medtronic stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 25.63% in 2026-2027.
We have gathered data from 18 analysts. Their low estimate is 2.83B, average is 5.72B and high is 6.47B.
What is Medtronic stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 3.57% in 2026-2027.
We have gathered data from 24 analysts. Their low revenue estimate is $34.89B, average is $35.02B and high is $35.23B.
What is Medtronic stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 24.89% in 2026-2027.
We have gathered data from 18 analysts. Their low earnings per share estimate is $2.13, average is $4.24 and high is $4.87.
What is the best performing analyst?
In the last twelve months 4 analysts have been covering Medtronic stock. The most successful analyst is David Rescott.